This content is supported by QOL Medical, LLC.

Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older. Sucraid® may cause a serious allergic reaction. If you notice any swelling or have difficulty breathing, get emergency help right away. Learn more about the risks here https://www.sucraid.com/risk#isi. See Prescribing Information at: https://bit.ly/2EyKpG5.